> Teva Pharmaceutical Industries CEO Erez Vigodman says the company will get rid of 11 plants as part of its cost cutting. Story
> Becton Dickinson, which last year got into the sterile injectable drug business, reported higher revenues in the first quarter. Release
> The FDA wants all generic drugmakers, including those that make active pharmaceutical ingredients, to self-identify so the FDA can inspect their plants and collect their fees. Story
> The FDA has sent a warning letter to Americare Compounding in Garden City South, NY, with observations about sterility. Letter
And Finally... A doctor writes in The New England Journal of Medicine that supplements with dangerous ingredients often remain on retailer shelves because of delays in the FDA finding out about them. Story (sub. req.)